1 Scope This document specifies the basic experimental requirements, pre-analysis preparation, methodology establishment and verification, quality management and result reporting and other technical indicators for clinical therapeutic drug monitoring using liquid chromatography-mass spectrometry technology. This document is applicable to the quality management of the establishment, verification and operation of clinical therapeutic drug monitoring methods using liquid chromatography-mass spectrometry technology and the development of related kits. 2 Normative references There are no normative references in this document.
T/CAS 678-2023 history
2023T/CAS 678-2023 General technical requirements for clinical therapeutic drug monitoring by liquid chromatography-mass spectrometry